Qiming Venture Partners Portfolio Companies Featured in QbitAI 2025 AIGC Companies and Products List
The ranking aims to offer an objective lens for understanding application trends in China's generative AI space, spotlighting early adopters and benchmark cases that dare to experiment and innovate.
Recently, QbitAI unveiled its 2025 list of AIGC companies and products to watch. The list aims to provide an objective perspective on China's generative AI (AIGC) application trends, spotlighting pioneers and benchmark cases that dare to experiment and innovate.
Portfolio companies of Qiming Venture Partners — StepFun, Meitu (01357.HK), Shengshu Technology, Infinigence AI, Unisound, Zhipu AI, and Zhihu (NYSE:ZH, 02390.HK) — were named to the list.
StepFun, Meitu, Shengshu Technology
Infinigence AI, Unisound, Zhipu AI
were named
2025 AIGC Companies to Watch
Shengshu Technology
(Vidu)
Meitu
(Meitu Design Studio)
Unisound
(Shouya AI)
Zhihu
(Zhihu Zhida)
Zhipu AI
(Zhipu AutoGLM)
were selected for the
2025 AIGC Products to Watch list
The 2025 AIGC Companies to Watch span the full generative AI value chain, from underlying infrastructure and foundation models to industry applications. Listees demonstrate strong technological innovation capabilities and extensive practical experience in application deployment, jointly driving the industrial adoption of generative AI technologies.
The 2025 AIGC Products to Watch cover diverse application scenarios, including AI content creation, AI customer service, AI coding assistants, and AI video generation. These products excel in both technological innovation and practical application, advancing the widespread use of generative AI and the healthy development of the industrial ecosystem.
In 2025, generative AI is entering a new phase of large-scale application. From breakthroughs in large language models to innovations in multimodal integration, generative AI has moved from the lab into real-world scenarios, becoming deeply embedded in content creation, enterprise services, industrial manufacturing, and other fields.
Source | QbitAI
Past Coverage
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its inception, the firm has focused on investing in outstanding early- and growth-stage companies in the Technology and Consumer (T&C) and Healthcare sectors.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have listed on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. Over 80 portfolio companies have become recognized unicorns or super-unicorns.
Many Qiming Venture Partners portfolio companies have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), GenScript ProBio (688520.SH), Yuanxin Technology, ClinChoice, Belief BioMed, Biren Technology, and others.